Clinical Trials Browser

Phase 1/2 × OTHER × Vaccinia × Clear all

NCT00116597 2009-12-02

Active Specific Intranodal Immunotherapy of Recombinant Vaccinia Virus in Locally Advanced to Metastatic Melanoma

Phase 1/2 Completed

Melanoma, Neoplasms, Vaccinia